Celldex Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2008 | — | — | $44.3M |
| Dec 2009 | — | — | $57.0M |
| Jun 2010 | — | — | $15.2M |
| Sep 2010 | — | — | $9.8M |
| Dec 2010 | $34.7M | $109.9M | $21.3M |
| Mar 2011 | — | — | $10.1M |
| Jun 2011 | $26.5M | $118.5M | $10.8M |
| Sep 2011 | $27.8M | $108.4M | $13.1M |
| Dec 2011 | $29.3M | $98.0M | $11.9M |
| Mar 2012 | $28.9M | $136.7M | $22.8M |
| Jun 2012 | $27.6M | $122.1M | $18.6M |
| Sep 2012 | $28.8M | $119.8M | $23.2M |
| Dec 2012 | $29.8M | $125.5M | $24.9M |
| Mar 2013 | $29.4M | $224.4M | $75.6M |
| Jun 2013 | $19.1M | $196.2M | $25.9M |
| Sep 2013 | $24.2M | $181.0M | $14.6M |
| Dec 2013 | $27.3M | $347.1M | $169.4M |
| Mar 2014 | $26.9M | $318.7M | $56.9M |
| Jun 2014 | $32.3M | $297.6M | $40.8M |
| Sep 2014 | $32.3M | $271.7M | $32.5M |
| Dec 2014 | $36.4M | $248.0M | $28.0M |
| Mar 2015 | $32.1M | $407.7M | $122.2M |
| Jun 2015 | $37.3M | $383.2M | $81.6M |
| Sep 2015 | $34.0M | $352.6M | $66.8M |
| Dec 2015 | $47.5M | $337.6M | $72.1M |
| Mar 2016 | $41.9M | $301.9M | $63.0M |
| Jun 2016 | $36.5M | $271.2M | $32.5M |
| Sep 2016 | $34.9M | $251.9M | $31.7M |
| Dec 2016 | $117.9M | $383.4M | $42.5M |
| Mar 2017 | $112.2M | $360.0M | $42.5M |
| Jun 2017 | $114.6M | $346.1M | $66.2M |
| Sep 2017 | $100.3M | $319.4M | $54.7M |
| Dec 2017 | $79.3M | $315.6M | $40.3M |
| Mar 2018 | $57.3M | $191.4M | $39.8M |
| Jun 2018 | $50.3M | $178.4M | $43.9M |
| Sep 2018 | $40.2M | $168.3M | $32.8M |
| Dec 2018 | $31.7M | $155.8M | $24.3M |
| Mar 2019 | $34.9M | $147.6M | $31.5M |
| Jun 2019 | $32.6M | $142.2M | $19.7M |
| Sep 2019 | $30.5M | $131.8M | $16.6M |
| Dec 2019 | $28.9M | $122.9M | $11.2M |
| Mar 2020 | $28.8M | $112.5M | $22.7M |
| Jun 2020 | $23.0M | $261.4M | $68.0M |
| Sep 2020 | $25.8M | $255.8M | $18.2M |
| Dec 2020 | $26.5M | $235.8M | $43.8M |
| Mar 2021 | $24.9M | $219.1M | $69.3M |
| Jun 2021 | $22.3M | $204.6M | $43.4M |
| Sep 2021 | $23.5M | $460.2M | $72.2M |
| Dec 2021 | $25.2M | $444.7M | $39.1M |
| Mar 2022 | $25.9M | $424.0M | $25.3M |
| Jun 2022 | $37.9M | $403.0M | $28.4M |
| Sep 2022 | $23.8M | $369.2M | $18.6M |
| Dec 2022 | $26.5M | $352.7M | $29.4M |
| Mar 2023 | $21.8M | $324.5M | $54.1M |
| Jun 2023 | $21.8M | $299.3M | $28.2M |
| Sep 2023 | $33.5M | $280.3M | $21.1M |
| Dec 2023 | $36.5M | $465.6M | $34.8M |
| Mar 2024 | $30.2M | $868.8M | $115.1M |
| Jun 2024 | $31.9M | $845.6M | $42.7M |
| Sep 2024 | $37.3M | $823.2M | $36.4M |
| Dec 2024 | $45.3M | $792.3M | $28.4M |
| Mar 2025 | $36.5M | $739.5M | $17.1M |
| Jun 2025 | $37.0M | $692.4M | $23.0M |
| Sep 2025 | $50.1M | $648.4M | $36.0M |
| Dec 2025 | $55.8M | $583.0M | $28.9M |
| Mar 2026 | $55.0M | $511.3M | $35.7M |
| Jun 2026 | $67.8M | $782.3M | $47.5M |